Oncolytics Biotech Inc

(NASDAQ:ONCY)

Latest On Oncolytics Biotech Inc (ONCY):

Date/Time Type Description Signal Details
2023-05-26 14:43 ESTNewsOncolytics falls 16% after mid-stage data for breast cancer therapyN/A
2023-05-05 17:10 ESTNewsOncolytics Biotech Inc. (ONCY) Q1 2023 Earnings Call TranscriptN/A
2023-05-05 17:10 ESTNewsOncolytics Biotech GAAP EPS of -$0.10 in-lineN/A
2023-05-04 15:09 ESTNewsOncolytics Biotech Q1 2023 Earnings PreviewN/A
2023-03-04 00:55 ESTNewsOncolytics Biotech Inc. (ONCY) Q4 2022 Earnings Call TranscriptN/A
2023-03-03 10:12 ESTNewsOncolytics Biotech GAAP EPS of -$0.14 misses by $0.07N/A
2022-12-01 15:27 ESTNewsOncolytics stock rises on FDA fast track tag for pelareorep to treat pancreatic cancerN/A
2022-11-07 22:47 ESTNewsOncolytics Biotech GAAP EPS of -C$0.08 in-lineN/A
2022-11-07 22:46 ESTNewsOncolytics Biotech, Inc. (ONCY) Q3 2022 Earnings Call TranscriptN/A
2022-11-04 23:54 ESTNewsOncolytics Biotech Q3 2022 Earnings PreviewN/A
2022-08-12 06:06 ESTNewsOncolytics Biotech Inc. (ONCY) CEO Matthew Coffey on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 13:32 ESTNewsOncolytics Biotech GAAP EPS of -$0.09 misses by $0.01N/A
2022-08-10 21:28 ESTNewsOncolytics Biotech Q2 2022 Earnings PreviewN/A
2022-05-06 06:02 ESTNewsOncolytics Biotech GAAP EPS of -$0.12 misses by $0.01N/A
2022-05-06 06:02 ESTNewsOncolytics Biotech, Inc. (ONCY) CEO Matthew Coffey on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-05 07:14 ESTNewsOncolytics Biotech Q1 2022 Earnings PreviewN/A
2022-03-31 14:53 ESTNewsOncolytics Biotech stock rises 11% on positive safety data from colorectal cancer therapyN/A
2022-03-04 09:13 ESTNewsOncolytics Biotech GAAP EPS of -C$0.14N/A
2022-03-04 09:13 ESTNewsOncolytics Biotech, Inc. (ONCY) CEO Matthew Coffey on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-02 22:44 ESTNewsOncolytics reports positive safety data in phase 1/2 pancreatic cancer groupN/A
2022-01-20 23:20 ESTNewsOncolytics rises 7% amid enrollment update on phase 1/2 gastrointestinal cancer studyN/A
2021-12-10 19:56 ESTNewsOncolytics Biotech jumps 9% on positive data for breast cancer candidateN/A
2021-11-06 06:17 ESTNewsOncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-05 11:05 ESTNewsOncolytics Biotech reports Q3 resultsN/A
2021-11-05 11:05 ESTNewsOncolytics rises premarket after Q3 2021 earnings beat, breast cancer dataN/A
2021-11-04 13:58 ESTNewsOncolytics Biotech Q3 2021 Earnings PreviewN/A
2021-11-03 16:43 ESTNewsOncolytics Biotech gets dosing underway in phase 1/2 pelareorep/atezolizumab cancer trialN/A
2021-10-14 22:52 ESTNewsOncolytics partner doses first patient in Chinese trial of pelareorep combo in breast cancerN/A
2021-10-12 10:56 ESTNewsWarning: ONCY is at high risk of performing badlyN/A
2021-10-06 14:17 ESTNewsONCY is at high risk of performing badlyN/A
2021-09-27 23:18 ESTNewsWarning: ONCY has been downgraded to Very BearishN/A
2021-09-23 09:09 ESTNewsWarning: ONCY has been downgraded to Very Bearish.N/A
2021-08-07 04:31 ESTNewsOncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-06 08:08 ESTNewsOncolytics Biotech EPS misses by $0.03N/A
2021-05-07 13:04 ESTNewsOncolytics Biotech reports Q1 resultsN/A
2021-04-07 01:14 ESTNewsOur First Look At Oncolytics BiotechN/A
2021-03-08 12:15 ESTFinancialsCompany financials have been released.Neutral
2021-03-06 00:06 ESTNewsOncolytics Biotech EPS misses by C$0.12N/A
2021-03-06 00:06 ESTNewsOncolytics Biotech secures $80M capital raiseN/A
2021-03-06 00:04 ESTNewsOncolytics Biotech Inc. (ONCY) CEO Dr. Matt Coffey on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-23 18:41 ESTNewsOncolytics surges on encouraging pelareorep + CAR T data in solid tumorsN/A
2020-11-26 21:06 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 04:59 ESTFinancialsCompany financials have been released.Neutral
2020-11-15 12:55 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 01:54 ESTNewsOncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-08 00:26 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:43 ESTFinancialsCompany financials have been released.Neutral
2020-10-31 23:13 ESTNewsOncolytics Bio teams up with Roche in gastrointestinal cancer trialN/A
2020-09-26 13:38 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:44 ESTFinancialsCompany financials have been released.Neutral

About Oncolytics Biotech Inc (ONCY):

Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an immuno-oncology viral-agent for the treatment of solid tumors and hematological malignancies. The company has collaboration agreements with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone-receptor positive, human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

ONCY Quotes by TradingView

See Advanced Chart

General

  • Name Oncolytics Biotech Inc
  • Symbol ONCY
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 25
  • Last Split Factor10:95
  • Last Split Date2018-05-25
  • Fiscal Year EndDecember
  • IPO Date1999-11-08
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.oncolyticsbiotech.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 8.32
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Return on Assets -59%
  • Return on Equity -183%
  • Earnings Per Share -$0.83
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 157.62 million
  • Book Value Per Share $0.40
View More

Share Statistics

  • Shares Outstanding 43.3 million
  • Shares Float 51.19 million
  • % Held by Insiders 124%
  • % Held by Institutions 1.85%
  • Shares Short 891018
  • Shares Short Prior Month 828747
  • Short Ratio 0.36
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 1.93
  • 52 Week High $4.19
  • 52 Week Low $1.06
  • 50 Day Moving Average 3
  • 200 Day Moving Average 2.46
View More

Dividends

  • Dividend Date 2018-05-25
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Oncolytics Biotech Inc (ONCY) Dividend Calendar:

ONCY's last dividend payment was made to shareholders on May 25, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Oncolytics Biotech Inc (ONCY) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-05$N/A-$0.17-$0.12-45.81%
2020-09-302020-11-11$N/A-$0.12-$0.10-21.91%
2020-06-302020-08-04$N/A-$0.13-$0.11-20.95%
2020-03-312020-05-08$N/A$0.03-$0.14121.01%
2019-12-312020-03-05$N/A-$0.62-$0.11-456.38%
2019-09-302019-11-12$N/A-$0.12-$0.1727.26%
2019-06-302019-08-13$N/A-$0.20-$0.19-3.36%
2019-03-312019-05-03$N/A-$0.20-$0.2210.58%
2018-12-312019-03-08$N/A-$0.21-$0.16-31.32%
2018-09-302018-11-12$N/A-$0.15-$0.1815.92%
2018-06-302018-08-03$N/A-$0.21-$0.226.6%
2018-03-312018-05-11$N/A-$0.22-$0.15-50.24%
2017-12-312018-03-09$N/A-$0.30-$0.24-26.06%
2017-09-302017-11-08$N/A-$0.15-$0.2436.52%
2017-06-302017-08-03$N/A-$0.23-$0.21-6.64%
2017-03-312017-05-05$N/A-$0.21-$0.211.74%
2016-12-312017-03-10$N/A-$0.35-$0.22-61.44%
2016-09-302016-11-03$N/A-$0.21-$0.223.62%
2016-06-302016-08-04$N/A-$0.15-$0.2132.07%
2016-03-312016-05-06$N/A-$0.22-$0.3128.46%
2015-12-312016-03-11$N/A-$0.22-$0.2824.22%
2015-09-302015-11-05$N/A-$0.02-$0.0450%
2015-06-302015-08-06$N/A-$0.03-$0.0425%
2015-03-312015-05-07$N/A-$0.04-$0.040%
2014-12-312015-03-16$N/A-$0.04-$0.0633.33%
2014-09-302014-11-06$N/A-$0.05-$0.0616.67%
2014-06-302014-08-07$N/A-$0.47-$0.6628.79%
2014-03-312014-05-08$N/A-$0.57-$0.6613.64%
2013-12-312014-03-13$N/A-$0.66-$0.8118.52%
2013-09-302013-11-07$N/A-$0.66-$0.660%
2013-06-302013-08-01$N/A-$0.57-$0.8734.48%
2013-03-312013-05-09$N/A-$0.76-$0.8510.59%
2012-12-312013-03-14$N/A-$1.04-$1.050.95%
2012-09-302012-11-08$N/A-$1.14-$1.07-6.54%
2012-06-302012-08-02$N/A-$1.24-$1.13-9.73%
2012-03-312012-05-10$N/A-$1.04-$1.2315.45%
2011-12-312012-03-15$N/A-$1.52-$0.96-58.33%
2011-09-302011-11-10$N/A-$0.85-$1.0115.84%
2011-06-302011-07-28$N/A-$0.85-$0.894.49%
2011-03-312011-05-12$N/A-$0.57-$0.8230.49%
2010-12-312011-03-17$N/A-$1.14-$0.89-28.09%
2010-09-302010-11-10$N/A-$0.66-$0.8623.26%
2010-06-302010-07-29$N/A-$0.66-$0.8522.35%
2010-03-312010-05-12$N/A-$0.66-$0.8522.35%
2009-12-312010-03-09$N/A-$0.85-$0.55-54.55%
2009-09-302009-11-05$N/A-$0.47-$0.6830.88%
2009-06-302009-07-29$N/A-$0.76-$0.73-4.11%
2009-03-312009-05-05$N/A-$0.85-$1.0115.84%
2008-12-312009-03-04$N/A-$0.85-$1.0519.05%
2008-09-302008-11-04$N/A-$0.95-$1.015.94%
2008-06-302008-07-29$N/A-$1.24-$0.99-25.25%
2008-03-312008-04-30$N/A-$0.76-$1.0426.92%
2007-12-312008-03-06$N/A-$0.85-$0.9510.53%
2007-09-302007-10-30$N/A-$0.83
2007-06-302007-07-27$N/A-$0.77
2007-03-312007-04-27$N/A-$0.87
2006-12-312007-03-02$N/A-$1.12
2006-09-302006-11-03$N/A-$0.80
2006-06-302006-07-26$N/A-$0.70
2006-03-312006-04-26$N/A-$0.68
2005-12-312006-03-03$N/A-$0.97
2005-09-302005-10-26$N/A-$0.85-$0.850%
2005-06-302005-07-27$N/A-$0.69
2005-03-312005-04-27$N/A-$0.57
2004-12-312005-02-15$N/A-$1.52-$0.95-60%
2004-09-302004-10-26$N/A-$0.76
2004-06-302004-08-05$N/A-$0.77
2004-03-312004-04-27$N/A-$0.71
2003-12-312004-03-08$N/A-$0.43
2003-09-302003-11-03$N/A-$0.50
2003-06-302003-08-05$N/A-$1.19
2003-03-312003-03-31$N/A-$0.32
2002-06-302002-06-30$N/A-$0.40

Oncolytics Biotech Inc (ONCY) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Oncolytics Biotech Inc (ONCY) Chart:

Oncolytics Biotech Inc (ONCY) News:

Below you will find a list of latest news for Oncolytics Biotech Inc (ONCY) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Oncolytics Biotech Inc (ONCY) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest ONCY Trades:

Date Shares Price
Jun 13, 2022 7:06 PM EST100$0.9649
Jun 13, 2022 7:39 PM EST100$0.9499

Oncolytics Biotech Inc (ONCY) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000043/0001129928-20-000043-index.htm
2020-01-03SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1129928/000110465920000915/0001104659-20-000915-index.htm
2020-03-09SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1129928/000110465920030320/0001104659-20-030320-index.htm
2020-04-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000110465920048027/0001104659-20-048027-index.htm
2020-06-08F-10Registration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1129928/000110465920070925/0001104659-20-070925-index.htm
2020-06-08F-XAppointment of Agent for Service of Process and Undertakinghttps://www.sec.gov/Archives/edgar/data/1129928/000110465920070932/0001104659-20-070932-index.htm
2020-06-12F-10/ARegistration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1129928/000110465920072747/0001104659-20-072747-index.htm
2020-06-16SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1129928/000110465920073470/0001104659-20-073470-index.htm
2020-06-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000110465920073481/0001104659-20-073481-index.htm
2020-06-25SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1129928/000110465920076534/0001104659-20-076534-index.htm
2020-06-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000110465920076538/0001104659-20-076538-index.htm
2018-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000039/0001129928-18-000039-index.htm
2018-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000041/0001129928-18-000041-index.htm
2018-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000044/0001129928-18-000044-index.htm
2018-08-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000047/0001129928-18-000047-index.htm
2018-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000049/0001129928-18-000049-index.htm
2018-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000051/0001129928-18-000051-index.htm
2018-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000053/0001129928-18-000053-index.htm
2018-09-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000055/0001129928-18-000055-index.htm
2018-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000057/0001129928-18-000057-index.htm
2018-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000059/0001129928-18-000059-index.htm
2018-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000061/0001129928-18-000061-index.htm
2018-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000063/0001129928-18-000063-index.htm
2018-10-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000065/0001129928-18-000065-index.htm
2018-10-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000067/0001129928-18-000067-index.htm
2018-10-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000069/0001129928-18-000069-index.htm
2018-11-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000071/0001129928-18-000071-index.htm
2018-11-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000073/0001129928-18-000073-index.htm
2018-11-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000075/0001129928-18-000075-index.htm
2018-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000079/0001129928-18-000079-index.htm
2018-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000081/0001129928-18-000081-index.htm
2018-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000083/0001129928-18-000083-index.htm
2018-11-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000086/0001129928-18-000086-index.htm
2018-11-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000088/0001129928-18-000088-index.htm
2018-12-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000090/0001129928-18-000090-index.htm
2018-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992818000092/0001129928-18-000092-index.htm
2019-02-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000002/0001129928-19-000002-index.htm
2019-02-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000004/0001129928-19-000004-index.htm
2019-02-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000006/0001129928-19-000006-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000010/0001129928-19-000010-index.htm
2019-03-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000011/0001129928-19-000011-index.htm
2019-03-1520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000014/0001129928-19-000014-index.htm
2019-03-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000019/0001129928-19-000019-index.htm
2019-03-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000020/0001129928-19-000020-index.htm
2019-04-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000022/0001129928-19-000022-index.htm
2019-04-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000025/0001129928-19-000025-index.htm
2019-05-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000027/0001129928-19-000027-index.htm
2019-05-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000029/0001129928-19-000029-index.htm
2019-05-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000031/0001129928-19-000031-index.htm
2019-05-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000033/0001129928-19-000033-index.htm
2019-06-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000035/0001129928-19-000035-index.htm
2019-07-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000037/0001129928-19-000037-index.htm
2019-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000044/0001129928-19-000044-index.htm
2019-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000046/0001129928-19-000046-index.htm
2019-08-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000048/0001129928-19-000048-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000050/0001129928-19-000050-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000052/0001129928-19-000052-index.htm
2019-08-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000054/0001129928-19-000054-index.htm
2019-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000056/0001129928-19-000056-index.htm
2019-09-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000058/0001129928-19-000058-index.htm
2019-10-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000060/0001129928-19-000060-index.htm
2019-10-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000062/0001129928-19-000062-index.htm
2019-10-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000064/0001129928-19-000064-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000066/0001129928-19-000066-index.htm
2019-11-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000068/0001129928-19-000068-index.htm
2019-11-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000070/0001129928-19-000070-index.htm
2019-11-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000072/0001129928-19-000072-index.htm
2019-11-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000075/0001129928-19-000075-index.htm
2019-11-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000077/0001129928-19-000077-index.htm
2019-11-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000078/0001129928-19-000078-index.htm
2019-12-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000080/0001129928-19-000080-index.htm
2019-12-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992819000082/0001129928-19-000082-index.htm
2020-01-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000002/0001129928-20-000002-index.htm
2020-01-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000004/0001129928-20-000004-index.htm
2020-01-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000006/0001129928-20-000006-index.htm
2020-03-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000008/0001129928-20-000008-index.htm
2020-03-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000010/0001129928-20-000010-index.htm
2020-03-0620-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000012/0001129928-20-000012-index.htm
2020-03-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000014/0001129928-20-000014-index.htm
2020-04-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000016/0001129928-20-000016-index.htm
2020-04-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000018/0001129928-20-000018-index.htm
2020-05-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000020/0001129928-20-000020-index.htm
2020-05-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000022/0001129928-20-000022-index.htm
2020-05-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000024/0001129928-20-000024-index.htm
2020-05-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000026/0001129928-20-000026-index.htm
2020-05-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000028/0001129928-20-000028-index.htm
2020-05-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000030/0001129928-20-000030-index.htm
2020-05-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000032/0001129928-20-000032-index.htm
2020-05-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000034/0001129928-20-000034-index.htm
2020-06-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000036/0001129928-20-000036-index.htm
2020-06-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000039/0001129928-20-000039-index.htm
2020-06-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000041/0001129928-20-000041-index.htm
2020-06-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000043/0001129928-20-000043-index.htm
2020-08-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000046/0001129928-20-000046-index.htm
2020-08-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000048/0001129928-20-000048-index.htm
2020-08-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000050/0001129928-20-000050-index.htm
2020-10-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000054/0001129928-20-000054-index.htm
2020-10-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000112992820000056/0001129928-20-000056-index.htm
2018-04-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000114420418022333/0001144204-18-022333-index.htm
2018-04-25F-10Registration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1129928/000114420418022351/0001144204-18-022351-index.htm
2018-04-25F-XAppointment of Agent for Service of Process and Undertakinghttps://www.sec.gov/Archives/edgar/data/1129928/000114420418022373/0001144204-18-022373-index.htm
2018-05-04F-10/ARegistration Statement for Securities of certain Canadian Issuers.https://www.sec.gov/Archives/edgar/data/1129928/000114420418025445/0001144204-18-025445-index.htm
2018-05-318-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1129928/000114420418032024/0001144204-18-032024-index.htm
2018-05-31SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1129928/000114420418032054/0001144204-18-032054-index.htm
2018-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000114420418032457/0001144204-18-032457-index.htm
2018-06-01SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1129928/000114420418032461/0001144204-18-032461-index.htm
2018-09-28SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1129928/000114420418051362/0001144204-18-051362-index.htm
2018-09-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000114420418051371/0001144204-18-051371-index.htm
2018-10-25SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1129928/000114420418055208/0001144204-18-055208-index.htm
2018-10-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000114420418055216/0001144204-18-055216-index.htm
2019-08-13SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1129928/000114420419039632/0001144204-19-039632-index.htm
2019-08-14SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1129928/000114420419040143/0001144204-19-040143-index.htm
2019-08-16SUPPLVoluntary Supplemental Material by Foreign Issuers [Section 11(a)]https://www.sec.gov/Archives/edgar/data/1129928/000114420419040329/0001144204-19-040329-index.htm
2019-08-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000114420419040344/0001144204-19-040344-index.htm
2018-05-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000127956918001056/0001279569-18-001056-index.htm
2018-05-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000127956918001180/0001279569-18-001180-index.htm
2018-05-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000127956918001202/0001279569-18-001202-index.htm
2018-06-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000127956918001208/0001279569-18-001208-index.htm
2018-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1129928/000127956918001246/0001279569-18-001246-index.htm
2018-05-31CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1129928/000135445718000174/0001354457-18-000174-index.htm
2018-05-07EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1129928/999999999518001161/9999999995-18-001161-index.htm
2020-06-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1129928/999999999520001434/9999999995-20-001434-index.htm
2018-06-05CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1129928/999999999718006164/9999999997-18-006164-index.htm